Mark Douglas Smith's most recent trade in Phreesia Inc was a trade of 7,000 Stock Option done . Disclosure was reported to the exchange on July 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Phreesia Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jul 2025 | 7,000 | 51,193 | - | - | Stock Option | |
| Phreesia Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.71 per share. | 02 Jul 2025 | 7,000 | 44,353 (0%) | 0% | 4.7 | 32,970 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 02 Jul 2025 | 7,000 | 37,353 (0%) | 0% | 29 | 203,000 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Grant, award, or other acquisition of securities at price $ 27.61 per share. | 25 Jun 2025 | 6,700 | 37,353 (0%) | 0% | 27.6 | 184,987 | Common Stock |
| Teladoc Health Inc | Mark Douglas Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 28,986 | 28,986 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Mark Douglas Smith | Director | Purchase of securities on an exchange or from another person at price $ 7.08 per share. | 15 Aug 2024 | 4,000 | 8,355 (0%) | 0% | 7.1 | 28,312 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.71 per share. | 18 Jul 2024 | 7,000 | 37,653 (0%) | 0% | 4.7 | 32,970 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 18 Jul 2024 | 7,000 | 30,653 (0%) | 0% | 25 | 175,000 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jul 2024 | 7,000 | 58,193 | - | - | Stock Option | |
| Phreesia Inc | Mark Douglas Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,490 | 30,653 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Mark Douglas Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 17,467 | 17,467 | - | - | Restricted Stock Units | |
| Phreesia Inc | Mark Douglas Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 6,051 | 22,163 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Mark Douglas Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 9,834 | 9,834 | - | - | Restricted Stock Units | |
| Phreesia Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.71 per share. | 03 Apr 2023 | 7,000 | 23,112 (0%) | 0% | 4.7 | 32,970 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 7,000 | 65,193 | - | - | Stock Option | |
| Phreesia Inc | Mark Douglas Smith | Director | Sale of securities on an exchange or to another person at price $ 30.69 per share. | 03 Apr 2023 | 6,500 | 16,612 (0%) | 0% | 30.7 | 199,482 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Sale of securities on an exchange or to another person at price $ 31.77 per share. | 03 Apr 2023 | 500 | 16,112 (0%) | 0% | 31.8 | 15,886 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 7,397 | 16,112 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Mark Douglas Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 6,726 | 6,726 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2022 | 819 | 819 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2022 | 819 | 4,355 (0%) | 0% | - | Common Stock | |
| Phreesia Inc | Mark Douglas Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2021 | 2,605 | 8,715 (0%) | 0% | 0 | Common Stock | |
| Teladoc Health Inc | Mark Douglas Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,638 | 1,638 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2021 | 524 | 3,536 (0%) | 0% | - | Common Stock | |
| Teladoc Health Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 May 2021 | 524 | 525 | - | - | Restricted Stock Units | |
| Phreesia Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.71 per share. | 04 Jan 2021 | 6,000 | 12,110 (0%) | 0% | 4.7 | 28,260 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 6,000 | 72,193 | - | - | Stock Option (Right to Buy) | |
| Phreesia Inc | Mark Douglas Smith | Director | Sale of securities on an exchange or to another person at price $ 52.07 per share. | 04 Jan 2021 | 2,911 | 9,199 (0%) | 0% | 52.1 | 151,567 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Sale of securities on an exchange or to another person at price $ 52.93 per share. | 04 Jan 2021 | 2,789 | 6,410 (0%) | 0% | 52.9 | 147,625 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Sale of securities on an exchange or to another person at price $ 54.06 per share. | 04 Jan 2021 | 300 | 6,110 (0%) | 0% | 54.1 | 16,219 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Sale of securities on an exchange or to another person at price $ 30.30 per share. | 10 Aug 2020 | 6,000 | 6,110 (0%) | 0% | 30.3 | 181,825 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.71 per share. | 10 Aug 2020 | 6,000 | 12,110 (0%) | 0% | 4.7 | 28,260 | Common Stock |
| Phreesia Inc | Mark Douglas Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2020 | 6,000 | 78,193 | - | - | Stock Option (Right to Buy) |